FDA Inspection 1115559 — Viatris Pharmaceuticals LLC

Viatris Pharmaceuticals LLC — FEI 2627208

The FDA completed an inspection of Viatris Pharmaceuticals LLC on December 20, 2019 in Barceloneta, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 20, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Barceloneta, PR (United States)